Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

Management of possible serious bacterial infections in young infants where referral is not possible in the context of existing health system structure in Mbeya, Tanzania: Experience and lessons from the end line assessment.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • معلومة اضافية
    • المصدر:
      Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE
    • بيانات النشر:
      Original Publication: San Francisco, CA : Public Library of Science
    • الموضوع:
    • نبذة مختصرة :
      Severe bacterial infections (SBIs) are a leading cause of neonatal deaths in low- and middle-income countries. World Health Organization's (WHO's) guideline for outpatient management of danger signs indicating possible serious bacterial infections (PSBI) when referral is not possible was adopted by three pilot district councils in Mbeya Region, in Tanzania (Busekelo, Kyela and Mbarali Districts) in 2018 (the PSBI project). This study documented changes in practice during the PSBI project, and lessons learned. A cross-sectional study was conducted using both qualitative and quantitative data collection methods between July 2021 and January 2022, post-implementation. The study participants comprised stakeholders, health workers, community health workers, and mothers/fathers/caregivers who had a young infant with PSBI. Study tools included record review, quantitative, in-depth, and key informant interviews. Quantitative data were analysed using STATA version 15 (STATACorp Inc., TX, USA), whereas qualitative data were analysed using a framework analysis approach. Our assessment showed that 2,228 young infants (0-59 days old) from the three districts were classified as having PSBI. The majority, 1,607 (72.1%) had fast breathing as the only danger sign, while 621 (27.9%) were classified as having severe illness. All 621 young infants with severe illness were counselled and offered referral to a higher-level health facility; however, only 174 of them (28%) accepted the referral. The remaining 447 severely ill infants, for whom referral was not possible, were treated at the primary health facilities with gentamicin injection and amoxicillin dispersible tablets (DT). When referral is not feasible, outpatient treatment for young infants with signs of PSBI is possible within existing health system in Tanzania, based on experience after this pilot project. However, successful scale-up of outpatient management for PSBI will require commitments from government and key stakeholders to strengthen healthcare systems.
      Competing Interests: The authors have declared that no competing interests exist.
      (Copyright: © 2024 Ngadaya et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.)
    • References:
      Lancet. 2005 Mar 5-11;365(9462):891-900. (PMID: 15752534)
      J Perinatol. 2005 Mar;25 Suppl 1:S62-71. (PMID: 15791280)
      Colorectal Dis. 2021 Jan;23(1):316-319. (PMID: 33320416)
      Int J Health Plann Manage. 2019 Oct;34(4):1265-1276. (PMID: 30994219)
      Pediatr Infect Dis J. 2012 Jul;31(7):667-72. (PMID: 22481421)
      Lancet. 2020 Jan 18;395(10219):200-211. (PMID: 31954465)
      BMC Health Serv Res. 2014 Feb 11;14:65. (PMID: 24511880)
      Lancet. 2015 May 2;385(9979):1758-1766. (PMID: 25842223)
      J Cancer Educ. 2022 Oct;37(5):1486-1495. (PMID: 33754327)
      Lancet Glob Health. 2021 Jan;9(1):e72-e80. (PMID: 33189189)
      Lancet. 1999 Dec 4;354(9194):1955-61. (PMID: 10622298)
      Lancet. 2021 Sep 4;398(10303):870-905. (PMID: 34416195)
      BMC Pregnancy Childbirth. 2015 Apr 30;15:106. (PMID: 25925407)
      J Clin Epidemiol. 2010 May;63(5):491-501. (PMID: 19540721)
      PLoS One. 2020 Aug 24;15(8):e0236355. (PMID: 32833993)
      J Perinatol. 2008 Dec;28 Suppl 2:S31-7. (PMID: 19057566)
      PLoS One. 2020 Dec 22;15(12):e0243724. (PMID: 33351810)
      J Gen Intern Med. 2019 Mar;34(3):458-463. (PMID: 30565151)
      Stat Med. 2012 Oct 30;31(24):2904-36. (PMID: 22714646)
      BMC Health Serv Res. 2023 Jan 19;23(1):56. (PMID: 36658537)
      BMC Pediatr. 2018 May 24;18(1):173. (PMID: 29793543)
      BMJ. 2019 Jan 17;364:k5408. (PMID: 30655245)
      J Gen Intern Med. 2016 Jan;31(1):13-21. (PMID: 26160480)
      Lancet. 2008 Jun 7;371(9628):1936-44. (PMID: 18539225)
      PLoS One. 2020 Jun 4;15(6):e0234212. (PMID: 32497092)
      Lancet. 2017 Dec 17;388(10063):3027-3035. (PMID: 27839855)
      Reprod Health. 2016 May 24;13(1):65. (PMID: 27221099)
      PLoS One. 2021 Jul 07;16(7):e0252700. (PMID: 34234352)
      BMC Health Serv Res. 2020 Mar 17;20(1):218. (PMID: 32183797)
      Hum Resour Health. 2012 Feb 22;10:3. (PMID: 22357353)
      Lancet. 2005 Mar 12-18;365(9463):977-88. (PMID: 15767001)
      Lancet Infect Dis. 2014 Aug;14(8):731-741. (PMID: 24974250)
      Glob Public Health. 2006;1(2):147-56. (PMID: 19153903)
    • الرقم المعرف:
      0 (Anti-Bacterial Agents)
    • الموضوع:
      Date Created: 20241205 Date Completed: 20241205 Latest Revision: 20241207
    • الموضوع:
      20241209
    • الرقم المعرف:
      PMC11620348
    • الرقم المعرف:
      10.1371/journal.pone.0310259
    • الرقم المعرف:
      39636929